Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase

Brain Research

Volumn 878, Issue 1-2, 2000, Pages 218-222

  Maragos, William F ^a,b   Jakel, Rebekah ^a   Chesnut, Dathan ^a   Pocernich, Chava B ^c   Butterfield, D Allan ^c   St Clair, Daret ^c   Cass, Wayne A ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Dopamine; Manganese superoxide dismutase; Methamphetamine; Oxidative stress; Striatum; Transgenic mouse

Indexed keywords

DOPAMINE; MANGANESE SUPEROXIDE DISMUTASE; METHAMPHETAMINE; MITOCHONDRIAL ENZYME; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN MITOCHONDRION; CONTROLLED STUDY; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMAL; CORPUS STRIATUM; DOPAMINE; HUMAN; METHAMPHETAMINE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; NERVE TISSUE PROTEINS; OXIDATION-REDUCTION; REFERENCE VALUES; SUPEROXIDE DISMUTASE; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0034730446     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02707-4     Document Type: Article

References (33)

1. Aksenov M.Y., Aksenova M.V., Carney J.M., Butterfield D.A. Oxidative modification of glutamine synthetase by amyloid beta peptide. Free Radic. Res. 27:1997;267-281.
2. Beauchamp C., Fridovich I. Superoxide dismutase: improved assays and an assay applicable to acrylamide gels. Analyt. Biochem. 44:1971;276-287.
3. Boveris A., Chance B. The mitochondrial generation of hydrogen peroxide. Biochem. J. 134:1973;707-716.
4. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Adv. Cell Aging Gerentol. 2:1997;161-191.
5. Cadet J.L., Sheng P., Syed A., Rothman R., Carlson E., Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62:1994;380-383.
6. Cappon G.D., Broening H.W., Pu C., Morford L., Vorhees C.V. α-Phenyl-N-tert-butyl nitrone attenuates methamphetamine-induced depletion of striatal dopamine without altering hyperthermia. Synapse. 24:1996;173-181.
7. Cass W.A. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J. Pharmacol. Exp. Ther. 280:1997;105-113.
8. Cheng N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., Misu Y. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons. Brain Res. 743:1996;278-283.
9. Cubells F.J., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14:1994;2260-2271.
10. DeVito M.J., Wagner G.C. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 28:1989;1145-1150.
11. Dykens J.A. Mitochondrial free radical production and oxidative pathophysiology: implications for neurodegenerative diseases. Beal M.F., Howell N., Bodis-Wollner I. Mitochondria and Free Radicals in Neurodegenerative Diseases. 1997;pp. 29-56 Wiley-Liss Inc, New York.
12. Filloux F., Wamsley J.K. Dopaminergic modulation of excitotoxicity in rat striatum: evidence from nigrostriatal lesions. Synapse. 8:1991;281-288.
13. Giovanni A., Liang L.P., Hastings T.G., Zigmond M.J. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine. J. Neurochem. 64:1995;1819-1825.
14. Gonzalez-Zulueta M., Ensz L.M., Mukhina G., Lebovitz R.M., Zwacka R.M., Engelhardt J.F., Oberley L.W., Dawson V.L., Dawson T.M. Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. J. Neurosci. 18:1998;2040-2055.
15. G Graham D., Tiffany S.M., Bell W.R., Gutknecht W.F. Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro. Mol. Pharmacol. 14:1978;644-653.
16. Guidot D.M., Repine F.J., Kitlowski A.D., Flores S.C., Nelson K., Wright S.R.M., McCord J.M. Mitochondrial respiration scavenges extramitochondrial superoxide anion via a nonenzymatic mechanism. J. Clin. Invest. 96:1995;1131-1136.
17. Hastings T.G., Lewis D.A., Zigmond M.L. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections. Proc. Natl. Acad. Sci. USA. 93:1996;1956-1961.
18. Hoyt K.R., Reynolds I.J., Hastings T.G. Mechanisms of dopamine-induced cell death in cultured rat forebrain neurons: interactions with and differences from glutamate-induced cell death. Exp. Neurol. 143:1997;269-281.
19. Keller J.N., Kindy M.S., Holtsberg F.W., St Clair D.K., Yen H., Germeyer A., Steiner S.M., Bruce-Keller A.J., Hutchins J.B., Mattson M.P. Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduced ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18:1998;687-697.
20. Klivenyi P., St Clair D., Wermer M., Yen H.C., Oberely T., Yang L., Beal M.F. Manganese superoxide dismutase overexpression attenuates MPTP toxicity. Neurobiol. Dis. 5:1998;253-258.
21. Kogan F.J., Nichols W.K., Gibb J.W. Influence of methamphetamine on nigral and striatal tyrosine hydroxylase activity and on striatal dopamine levels. Eur. J. Pharmacol. 36:1976;363-371.
22. LaVoie M.J., Hastings T.G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19:1999;1484-1491.
23. Kajima H.J., Oberley T.D., Furukawa K., Mattson M.P., Yen H., Szweda L.I., St Clair D.K. Prevention of mitochondrial injury by manganese superoxide dismutase reveals a primary mechanism for alkaline-induced cell death. J. Biol. Chem. 273:1998;8217-8224.
24. McLaughlin B.A., Nelson D., Erecinska M., Chesselet M.-F. Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor. J. Neurochem. 70:1998;2406-2415.
25. Rosenberg P.A. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J. Neurosci. 8:1988;2887-2894.
26. Smith T.S., Parker W.D., Bennett J.P. L-dopa increases nigral production of hydroxyl radicals in vivo: potential L-dopa toxicity. NeuroReport. 5:1994;1009-1011.
27. Spina M.B., Cohen G. Dopamine turnover and glutathione oxidation: implications for Parkinson disease. Proc. Natl. Acad. Sci. USA. 86:1989;1398-1400.
28. Sullivan P.G., Bruce-Keller A.J., Rabchevsky A.G.S., Christakos S., St Clair D.K., Mattson M.P., Scheff S.W. Exacerbation of damage and altered NF-κB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 19:1999;6248-6256.
29. Wagner G.C., Ricaurte G.A., Seiden L.S., Schuster C.R., Miller R.J., Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 181:1980;151-160.
30. Wagner G.C., Carelli R.M., Jarvis M.F. Pretreatment with ascorbic acid attenuates the neurotoxic effects of methamphetamine in rats. Res. Comm. Chem. Path. Pharmacol. 47:1985;221-228.
31. Weisiger R.A., Fridovich I. Mitochondrial superoxide dismutase. J. Biol. Chem. 248:1973;4793-4796.
32. Yen H.C., Oberley T.D., Vichitbandha S., Ho Y.S., St Clair D.K. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. J. Clin. Invest. 98:1996;1253-1260.
33. Yen H.C., Oberley T.D., Gairola G.C., Szweda L.I., St Clair D.K. Manganese superoxide dismutase protects mitochondrial complex 1 against adriamycin-induced cardiomyopathy in transgenic mice. Arch. Biochem. Biophys. 362:1998;59-66.